1:51 PM
Oct 10, 2017
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Renal cancer

Patient sample and cell culture studies suggest promoting FILNC1 expression could help treat clear cell renal cell carcinoma (ccRCC). In tissue samples from patients, levels of FILNC1 were lower in tumors than in corresponding normal...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$18 USD
More Info >